Expression of CD68 positive macrophages in the use of different barrier materials to prevent peritoneal adhesions—an animal study

Journal of Materials Science: Materials in Medicine

Volumn 28, Issue 1, 2017, Pages

  Brochhausen, Christoph ^a   Schmitt, Volker H ^b   Mamilos, Andreas ^a   Schmitt, Christine ^c   Planck, Constanze N E ^d,e   Rajab, Taufiek K ^f   Hierlemann, Helmut ^e,g   Kirkpatrick, C James ^h  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c St Vinzenz und Elizabeth Hospital   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e German Centre of Biomaterials and Artificial Organs eV   (Germany)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Institute of Textile Technology and Process Engineering   (Germany)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; ANIMALS; BIOCOMPATIBILITY; BIOMATERIALS; PATHOLOGY; TISSUE; TISSUE REGENERATION;

ADHESION BARRIER; ADHESION PREVENTIONS; BARRIER MATERIAL; BIOMATERIAL TESTING; FOREIGN BODY REACTIONS; MACROPHAGE INFILTRATIONS; POSTOPERATIVE ADHESION FORMATION; POTENTIAL BARRIERS;

MACROPHAGES;

BIOMATERIAL; CD68 ANTIGEN; CHLORACETATE ESTERASE; ENZYME; UNCLASSIFIED DRUG; CD68 PROTEIN, RAT; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADHESION BARRIER; ADHESION BARRIER FILM; ADHESION BARRIER GEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; ARTICLE; COLLAGEN FIBER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROSIS; FOREIGN BODY REACTION; GIANT CELL; GRANULOCYTE; IMMUNOHISTOLOGY; INFLAMMATION; MACROPHAGE; MORPHOMETRY; NEUTROPHIL; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL; RAT; TISSUE REACTION; WOUND HEALING; ANIMAL; CELL ADHESION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; PATHOLOGY; PERITONEUM; PHYSIOLOGY; REGENERATION; TISSUE ADHESION; WISTAR RAT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOCOMPATIBLE MATERIALS; CELL ADHESION; FEMALE; FIBROSIS; FOREIGN-BODY REACTION; INFLAMMATION; MACROPHAGES; PERITONEUM; RATS; RATS, WISTAR; REGENERATION; TISSUE ADHESIONS; WOUND HEALING;

EID: 85006482406     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-016-5821-3     Document Type: Article

References (43)

1. Weibel MA, Majno G. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg. 1973;126(3):345–53.
2. Al-Jabri S, Tulandi T. Management and prevention of pelvic adhesions. Semin Reprod Med. 2011;29(2):130–7.
3. diZerega GS, Tulandi T. Prevention of intra-abdominal adhesions in gynaecological surgery. Reprod Biomed Online. 2008;17(3):303–6.
4. Cheong YC, Laird SM, Li TC, Shelton JB, Ledger WL, Cooke ID. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update. 2001;7(6):556–66.
5. Boland GM, Weigel RJ. Formation and prevention of postoperative abdominal adhesions. J Surg Res. 2006;132(1):3–12.
6. Almeida OD Jr., Val-Gallas JM. Conscious pain mapping. J Am Assoc Gynecol Laparosc. 1997;4(5):587–90.
7. Rajab TK, Wallwiener M, Talukdar S, Kraemer B. Adhesion-related complications are common, but rarely discussed in preoperative consent: a multicenter study. World J Surg. 2009;33(4):748–50.
8. Howard FM, El-Minawi AM, Sanchez RA. Conscious pain mapping by laparoscopy in women with chronic pelvic pain. Obstet Gynecol. 2000;96(6):934–9.
9. Ray NF, Larsen JW Jr., Stillman RJ, Jacobs RJ. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet. 1993;176(3):271–6.
10. Ray NF, Denton WG, Thamer M, Henderson SC, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998;186(1):1–9.
11. Hills BA, Burke JR, Thomas K. Surfactant barrier lining peritoneal mesothelium: lubricant and release agent. Perit Dial Int. 1998;18(2):157–65.
12. Chailley-Heu B, Rubio S, Rougier JP, Ducroc R, Barlier-Mur AM, Ronco P, et al. Expression of hydrophilic surfactant proteins by mesentery cells in rat and man. Biochem J. 1997;328(Pt 1):251–6.
13. Beavis J, Harwood JL, Coles GA, Williams JD. Synthesis of phospholipids by human peritoneal mesothelial cells. Perit Dial Int. 1994;14(4):348–55.
14. Hellebrekers BW, Kooistra T. Pathogenesis of postoperative adhesion formation. Br J Surg. 2011;98(11):1503–16.
15. Klein CL, Bittinger F, Skarke CC, Wagner M, Kohler H, Walgenbach S, et al. Effects of cytokines on the expression of cell adhesion molecules by cultured human omental mesothelial cells. Pathobiology. 1995;63(4):204–12.
16. Brochhausen C, Schmitt VH, Planck CNE, Rajab TK, Hollemann D, Tapprich C, et al. Current strategies and future perspectives for intraperitoneal adhesion prevention. J Gastrointest Surg. 2012;16(6):1256–74. doi:10.1007/s11605-011-1819-9.
17. Bittinger F, Klein CL, Skarke C, Brochhausen C, Walgenbach S, Rohrig O, et al. PECAM-1 expression in human mesothelial cells: an in vitro study. Pathobiology. 1996;64(6):320–7.
18. Bittinger F, Brochhausen C, Kohler H, Lehr HA, Otto M, Skarke C, et al. Differential expression of cell adhesion molecules in inflamed appendix: correlation with clinical stage. J Pathol. 1998;186(4):422–8.
19. Hellebrekers BW, Emeis JJ, Kooistra T, Trimbos JB, Moore NR, Zwinderman KH, et al. A role for the fibrinolytic system in postsurgical adhesion formation. Fertil Steril. 2005;83(1):122–9.
20. Holmdahl L. Making and covering of surgical footprints. Lancet. 1999;353(9163):1456–7.
21. Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril. 2005;83(2):405–9.
22. diZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update. 2001;7(6):547–55.
23. Thaler K, Mack JA, Berho M, Grotendorst G, Wexner SD, Abramson SR. Coincidence of connective tissue growth factor expression with fibrosis and angiogenesis in postoperative peritoneal adhesion formation. Eur Surg Res. 2005;37(4):235–41.
24. Brochhausen C, Schmitt VH, Krämer B, Rajab TK, Wallwiener M, Planck CNE, et al. Intraperitoneale Adhäsionen - Eine Herausforderung an der Schnittstelle von Materialforschung und Biomedizin. BIOmaterialien. 2009;10:7–17.
25. Brochhausen C, Schmitt VH, Rajab TK, Planck CNE, Kramer B, Wallwiener M, et al. Intraperitoneal adhesions-an ongoing challenge between biomedical engineering and the life sciences. J Biomed Mater Res A. 2011;98(1):143–56.
26. Schmitt VH. Die Biokompatibilität peritonealer Adhäsions barrieren–Histologie, Immunhistochemie und Ultrastruktur der Gewebe-Material-Interaktion. Heidelberg: Springer Research; 2016.
27. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol. 2001;53(4):386–92.
28. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958–69.
29. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg. 2005;31(6):674–86. discussion 86.
30. ISO/FDIS 10993-6:2007(E): Biological evaluation of medical devices - Part 6: Tests for local effects after implantation.
31. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30(3):245–57.
32. Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003;73(2):209–12.
33. Kou PM, Babensee JE. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A. 2011;96(1):239–60.
34. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176(1):287–92.
35. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323–50.
36. Xia Z, Triffitt JT. A review on macrophage responses to biomaterials. Biomed Mater. 2006;1(1):R1–9.
37. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–86.
38. Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond). 2003;104(1):27–38.
39. Fleming BD, Mosser DM. Regulatory macrophages: setting the threshold for therapy. Eur J Immunol. 2011;41(9):2498–502.
40. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109(1):429–40.
41. Yoshikawa K, Umeyama K, Yamashita T, Ishikawa T, Katoh N, Satake K. Immunological studies of the pathogenesis of idiopathic portal hypertension. J Gastroenterol Hepatol. 1989;4(Suppl 1):55–7.
42. Cao B, Guo Z, Zhu Y, Xu W. The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis. Chin Med J (Engl). 2000;113(9):776–82.
43. Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol. 2000;204(1):19–28.